Get to know our clinical trials
Long-term follow-up of patients exposed to lentiviral vector-based CART cell therapy.
THIS IS A LONG-TERM FOLLOW-UP TRIAL SPONSORED (FUNDED) BY THE PHARMACEUTICAL COMPANY NOVARTIS. IF YOU AGREE TO PARTICIPATE IN THIS STUDY, YOU WILL BE FOLLOWED FOR UP TO 15 YEARS AFTER YOUR LAST INFUSION OF YOUR CART CELLS TO ASSESS BOTH THE SAFETY AND RISK OF LATE SAFETY PROBLEMS SUSPECTED TO BE RELATED TO THE TREATMENT OF YOUR CART CELLS, OR CERTAIN LABORATORY PARAMETERS, AND EFFICACY INCLUDING THE STATUS OF YOUR PRIMARY MALIGNANCY.
Technical Summary
- LONG-TERM FOLLOW-UP OF PATIENTS EXPOSED TO LENTIVIRAL VECTOR-BASED CART CELL THERAPY.
- Code EudraCT: 2014-001673-14
- Protocol number: CCTL019A2205B
- Promoter: Novartis Farmaceutica
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.